Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.
Gauthier J, Gazeau N, Hirayama AV, Hill JA, Wu V, Cearley A, Perkins P, Kirk A, Shadman M, Chow VA, Gopal AK, Hodges Dwinal A, Williamson S, Myers J, Chen A, Nagle S, Hayes-Lattin B, Schachter L, Maloney DG, Turtle CJ, Sorror ML, Maziarz RT.
Gauthier J, et al. Among authors: nagle s.
Blood. 2022 Jun 30;139(26):3722-3731. doi: 10.1182/blood.2021014497.
Blood. 2022.
PMID: 35439295
Free PMC article.